Skip to main content
. 2019 Jan 29;10(4):937–948. doi: 10.7150/jca.27199

Table 3.

Univariate and multivariate variance analysis for PD-L1 and PD-1 expression.

PD-L1 PD-1
Univariate Multivariate Univariate Multivariate
Variables Mean (SD) p-value F p-value Mean (SD) p-value F p-value
Age <60 6.20(1.55) 0.054 5.24(1.76) 0.164
>=60 6.48(1.69) 5.45(1.55)
P16 Negative 6.55(1.54) 0.860 5.30(1.64) 0.0002 4.66 0.033
Positive 6.45(1.66) 6.62(1.85)
Stage I 7.17(1.68) 0.019 3.64 0.013 5.70(1.34) 0.407
II 6.67(1.55) 5.42(1.83)
III 6.34(1.82) 5.29(1.61)
IV 6.21(1.54) 5.20(1.62)
EGFR Unamplified 6.50(1.50) 0.680 5.74(1.70) 0.211
Amplified 6.95(1.92) 4.85(1.87)
Grade GX 6.69(1,23) 0.723 6.07(2.15) 0.001
G1 6.53(1.67) 5.27(1.58)
G2 6.28(1.58) 5.14(1.55)
G3 6.40(1.75) 5.74(1.70)
G4 6.41(1.30) 6.53(1.57)
Radiosensitivity RR 4.44(1.30) <0.0001 32.35 <0.0001 6.01(1.58) 0.0001 96.04 <0.0001
RS 6.64(1.15) 6.85(1.62)

Abbreviations: Grade, neoplasm histologic grade; EGFR, Epidermal growth factor receptor amplification status; RR, radioresistant group; RS, radiosensitive group.